1Gertz E W,Wisneski JA,Chiu D,et al.Clinical superiority of a new nonionic contrast agent(iopamidol)for cardiac angiography[J].J Am Coll Cardiol,1985,(5):250-258.
2Leonid L,Andrei M,Israela B.Nano-particles with contrast agents for diagnostic delivery system for X-ray and CT:WO,2007129311[P].2007-11-15.
3Yanaga Y,Awai K,Nakayama Y,et al.Optimal dose and injection duration(injection rate)of contrast material for depiction of hypervascular hepatocellular carcinomas by mutidetector CT[J].Radiat Med,2007,25(6):278-288.
3Gertz EW, Wisneski JA, Chiu D, et al. Clinical superiority of a new nonionic contrast agent (iopamidol) for cardiac angiography [J]. J Am Coll Cardiol, 1985, (5) : 250-258.
4Leonid L, Andrei M, Israela B. Nano-particles with contrast agents for diagnostic delivery system for X-ray and CT: WO, 2007129311 [P]. 2007-11-15.
5Yanaga Y, Awai K, Nakayama Y, et al. Optimal dose and injection duration(injection rate) of contrast material for depiction of hypervascular hepatocellular carcinomas by multidetector CT [J]. Radiat Med, 2007, 25 (6) : 278-288.
10Hughes AD, Price DA, Simpkis NS. Atropisomeric amides: stereoselective enolate chemistry and enantioselective synthesis via a new Sm12-mediated reduction [J]. J Chem Soc, Perkin Trans 1, 1999, (10) : 1295-1304.
